glp-1 and dizziness Does Cause Dizziness? Genetic & Biomarker Context – PlexusDx glp-1 receptor agonists dizziness side

It is a glucagon-like peptide-1 (GLP-1) receptor agonist that works by stimulating insulin secretion when blood glucose levels are elevated, suppressing glucagon release, and slowing gastric emptying

In the absence of a formal match in such clinical-level data on risk factors, is possible that the higher HbA1c drove at least part of the worse cardiovascular outcomes of patients in the BI group [33, 34]

BPC-157, originally isolated from human gastric juice in the 1990s, is a 15-amino acid peptide with remarkable stability and cytoprotective properties

This indirect approach produces modest insulin release and typically causes minimal weight loss, distinguishing it from direct GLP-1 agonist therapy

In aged human pinealocytes, Epitalon selectively safeguarded cells from degenerative changes, suggesting a tissue-specific rejuvenating effect on the very gland responsible for circadian control

FIGURE 5 Using ulcerative colitis as the search keyword, we screened five databases related to UC-associated genes